Pergamum appoints Jan Nilsson as Chief Marketing Officer

Pergamum appoints Jan Nilsson as Chief Marketing Officer

ID: 54631

(Thomson Reuters ONE) -



Stockholm, May 13, 2011. Pergamum has appointed Jan Nilsson as Chief Marketing
Officer and as Managing Director of the LL-37 program - Pergamum's program for
wound healing in chronic leg ulcers. Jan Nilsson has previously held a number of
executive leadership positions within international life science companies.
Also, he has worked as an executive consultant and advisor for a number of
smaller biotechs.

"Jan Nilsson will provide significant leadership capabilities to Pergamum. In
his role as Chief Marketing Officer, he will strengthen our ability to design
our development programs based on market and customer input. He will be able to
transform our longterm research focus into specialist care products.
Furthermore, Jan's experience in both small molecules and biopharmaceuticals
will be of great importance for the continued development of the company," says
Pergamum's CEO Jonas Ekblom.

"I am really excited about joining Pergamum. I strongly believe in Pergamum's
strategy and focused ambitions to become a strong, international company within
skin infections and wound healing. And - I believe Pergamum has great
opportunities within to the area of therapeutic peptides," says Jan Nilsson.

Jan Nilsson will assume his position during the second quarter of 2011.



For more information, please contact:

Jonas Ekblom, CEO        Phone: +46-8-524 89 100
Email:  jonas.ekblom(at)pergamum.com



About Pergamum
Pergamumis a biopharmaceutical company specialized in the development of
therapeutic peptides for treatment of skin infections and wounds. Within
Pergamum, companies and projects are managed as fully integrated operating units
with access to a core team of experienced professionals within drug development
and business management. This model provides Pergamum with an attractive




diversified product pipeline, while minimizing development cost and time-to-
market and mitigating risk. Three programs are currently in clinical
phase.www.pergamum.com





Pergamum appoints Jan Nilsson as Chief Marketing Officer:
http://hugin.info/144419/R/1514787/450910.pdf




This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Pergamum AB via Thomson Reuters ONE

[HUG#1514787]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  MediGene Reports Profit for the First Three Months of 2011 Q1 2011: Building strongest backlog ever amidst subdued markets
Bereitgestellt von Benutzer: hugin
Datum: 13.05.2011 - 07:30 Uhr
Sprache: Deutsch
News-ID 54631
Anzahl Zeichen: 2923

contact information:

Kategorie:

Business News



Diese Pressemitteilung wurde bisher 221 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Pergamum appoints Jan Nilsson as Chief Marketing Officer"
steht unter der journalistisch-redaktionellen Verantwortung von

Pergamum AB (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Pergamum AB



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z